Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. The Company agrees to furnish supplementally an unredacted copy of the exhibit to...Warrant Indenture • April 2nd, 2024 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
TSX TRUST COMPANY, a trust company existing under the laws of Canada and authorized to carry on business in all provinces of Canada (the "Warrant Agent"),
INDENTURE Made as of January 31, 2018 Between ORGANIGRAM HOLDINGS INC. (the “Corporation”) and TSX TRUST COMPANY (the “Trustee”)Indenture • April 29th, 2019 • Organigram Holdings Inc. • Ontario
Reference is hereby made to the Indenture, dated as of January 31, 2018 (the “Indenture”), between ORGANIGRAM HOLDINGS INC., as issuer (the “Corporation”), and TSX TRUST COMPANY, as trustee. Capitalized terms used but not defined herein shall have the meanings given to them in the Indenture.
ORGANIGRAM HOLDINGS INC. $49,000,000 EQUITY DISTRIBUTION AGREEMENTEquity Distribution Agreement • April 22nd, 2020 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
BMO Nesbitt Burns Inc. First Canadian Place, 4th Floor 100 King Street West Toronto, ON M5X 1H3 BMO Capital Markets Corp. 3 Times Square New York, NY 10036
ORGANIGRAM HOLDINGS INC. as Borrower - and - THE LENDERS FROM TIME TO TIME PARTY TO THIS AGREEMENT as Lenders - and - BANK OF MONTREAL as Administrative Agent - and - BANK OF MONTREAL as Lead Arranger and Sole Bookrunner AMENDED AND RESTATED CREDIT...Credit Agreement • November 30th, 2020 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM HOLDINGS INC.Investor Rights Agreement • January 24th, 2024 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
This AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT dated January 23, 2024 (this "Agreement") is made by and between BT DE Investments Inc., a corporation existing under the Laws of the State of Delaware (the "BAT Shareholder"), and Organigram Holdings Inc., a corporation existing under the Act (the "Company").
SUBSCRIPTION AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM HOLDINGS INC.Subscription Agreement • March 19th, 2021 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
This SUBSCRIPTION AGREEMENT dated March 10, 2021 (this "Agreement") is made by and between BT DE Investments Inc., a corporation existing under the Laws of the State of Delaware (the "Purchaser"), and Organigram Holdings Inc., a corporation existing under the Act (the "Company").
FIRST AMENDMENT TO CREDIT AGREEMENTCredit Agreement • June 2nd, 2020 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
NOW THEREFORE for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged by each party, the parties agree as follows:
AMENDMENT TO SUBSCRIPTION AGREEMENTSubscription Agreement • December 27th, 2023 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
This AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENT dated January ●, 2024 (this “Agreement”) is made by and between BT DE Investments Inc., a corporation existing under the Laws of the State of Delaware (the “BAT Shareholder”), and Organigram Holdings Inc., a corporation existing under the Act (the “Company”).
SUBSCRIPTION AGREEMENT between BT DE INVESTMENTS INC. and ORGANIGRAM HOLDINGS INC.Subscription Agreement • November 8th, 2023 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
This SUBSCRIPTION AGREEMENT dated November 5, 2023 (this "Agreement") is made by and between BT DE Investments Inc., a corporation existing under the Laws of the State of Delaware (the "Purchaser"), and Organigram Holdings Inc., a corporation existing under the Act (the "Company").
March 10, 2021 BT DE INVESTMENTS INC. and ORGANIGRAM INC. COLLABORATION AGREEMENT Herbert Smith Freehills LLPCollaboration Agreement • March 19th, 2021 • Organigram Holdings Inc. • Pharmaceutical preparations • England and Wales
AMENDED AND RESTATED UNDERWRITING AGREEMENTUnderwriting Agreement • November 12th, 2020 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
SECOND AMENDMENT TO CREDIT AGREEMENTCredit Agreement • June 2nd, 2020 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
WHEREAS the undersigned are parties to the credit agreement dated as of May 31, 2019 as amended by a first amendment dated November 15, 2019 (as amended, the "Credit Agreement");
Organigram and InterCure (dba : Canndoc) Sign New International Strategic Agreement Representing Largest Such Deal to Date for Both CompaniesStrategic Supply Agreement • November 17th, 2022 • Organigram Holdings Inc. • Pharmaceutical preparations
TORONTO & HERZILA, Israel--(BUSINESS WIRE)--November 17, 2022--Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI), ( “Organigram”) a leading Canadian licensed producer of cannabis and Canndoc Ltd. (“Canndoc”), a subsidiary of InterCure Ltd. (NASDAQ: INCR) (TSX:INCR.U) (TASE:INCR) (dba Canndoc) Israel’s largest and most established pharmaceutical cannabis producer, today jointly announced that they have entered into a new multi-year agreement (the “New Strategic Agreement”) for Organigram to continue supply of dried flower to InterCure.
SHARE PURCHASE AGREEMENT DECEMBER 6, 2024Share Purchase Agreement • December 17th, 2024 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
WHEREAS, Motif Labs Ltd. (the "Target Entity") carries on the business of licensed cannabinoid extraction, purification and formulation, the development, production and commercialization of cannabis products and the management of brands associated with such products (the "Business").
Certain portions of this exhibit have been redacted as they are both not material and are of the type of information that the Company treats as private or confidential. The Company agrees to furnish supplementally an unredacted copy of the exhibit to...Underwriting Agreement • March 28th, 2024 • Organigram Holdings Inc. • Pharmaceutical preparations • Ontario
